They are confident about FDA approval so far into the trails. Blockbuster drug Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer is far excedding there expectation This stock could run up 100 times from this level of .0008 easy
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.